miércoles, 18 de septiembre de 2019

New CF Treatment Candidate AP-PA02 Targets P. Aeruginosa Infections

New CF Treatment Candidate AP-PA02 Targets P. Aeruginosa Infections

Cystic Fibrosis News Today

Recent News

Reflecting on the First Year of My Column, ‘Mutations & Conversations’
Armata Announces New Treatment Candidate for P. Aeruginosa Infections in CF Patients
New Agreement in Scotland Grants CF Patients Access to Orkambi and Symkevi
Safety, Early Effectiveness of POL6014 Confirmed in Phase 1 Trial
ICER Seeking Feedback on CF Treatments from Stakeholders

No hay comentarios:

Publicar un comentario